Rodney Sinclair who is a famous hair loss researcher that I have covered a few times on this blog
In laboratory trials it has been shown to cause tumors in the thyroid (including cancer) in some cases
When you look at the therapeutic landscape, what stands out is that muvalaplin (from Eli Lilly and Company) is currently the most advanced, and the first oral small molecule to demonstrate robust Lp(a) lowering in humans, specifically developed for this target, while most of the field is focused on injectable siRNA and antisense approaches
Consultado el 16 de diciembre de 2009
PlexusDx recommends working with a licensed provider to optimize a single compound based on your genetic profile instead
For the bigger research picture, read the BPC-157 research guide on how it works, key studies, safety notes, and common comparisons